Initial ADT reduced PSA from 78 to 17 ng/mL and improved pain score from 6/10 to 3/10 Abiraterone acetate (1000 mg daily with 5 mg prednisone twice a day) further suppressed PSA to 9 ng/mL Patient ...

The relationship between clinical trial results and real-world experience with enzalutamide and darolutamide shows important patterns: The alignment between trial data and clinical experience supports ...

John Michael DiBianco, MD, discusses findings from the BLUES trial. A recent study evaluated silicone vs polyurethane stents found that the primary outcome of pain intensity and interference at 7 to ...

Helen Bernie, DO, MPH, joins the show to discuss data from her Indiana University team from the floor at AUA 2025.

The Hugo robotic surgical platform showed high efficacy with a 98.5% surgical success rate, exceeding the 85% performance goal. Safety was confirmed with low rates of grade 3 or higher Clavien-Dindo ...

Investigators found that benefits of treatments that are observed in trials also appear in the real world. A recent study examined the relationship between randomized controlled trials and real-world ...

Among the guideline’s recommendations is the use of local low-dose vaginal estrogen as first-line therapy for GSM. The recent release of the “Genitourinary Syndrome of Menopause: AUA/SUFU [Society of ...

Paul E. Dato, MD, discusses how when selecting abiraterone for metastatic hormone-sensitive prostate cancer patients, there are 3 formulations to consider: standard, generic, and micronized versions, ...

Panelists discuss how evaluating a renal mass requires considering multiple factors, including patient expectations, comorbidities, life expectancy, tumor characteristics such as size and enhancement ...

Nearly 60% of patients taking vibegron remained on treatment at 1 year. The real-world, phase 4 COMPOSUR study (NCT05067478) found that nearly 60% of patients taking vibegron remained on treatment at ...

Black men experience a 67% higher incidence of prostate cancer compared with all races/ethnicities. There is a more than 2-fold higher risk of mortality for Black men with prostate cancer. Significant ...

"The black box warning affects that ability for them to get access to that critical drug, vaginal estrogen," says Yahir A. Santiago-Lastra, MD. At the 2025 American Urological Association Annual ...